Zhiqiang An

56PUBLICATIONS
248CO-AUTHORS
Bioinformatic methods developmentBiologically active moleculesPredictive and prognostic markersMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Aug 20, 2026
A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.

|Jul 01, 2026
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics.

|Jun 03, 2026
Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in KRAS-mutant non-small cell lung cancer.

|Apr 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates.

Aiko Yamaguchi, Junping Hong, Leike Li

|Apr 03, 2026
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer.

Xiaoye Liu, Ryan Huang, Zhiqiang Ku

|Mar 20, 2026
Coexpression of IL15 Promotes Effector Differentiation and Sustained Proliferative Capacity in ALPPL2-Specific Human CAR T Cells.

David Cunningham, Junquan Liu, Inci Cevher Zeytin

Pageof 10

Frequent Collaborators

32 joint publications

Ningyan Zhang

7 joint publications

Pei-Yong Shi

7 joint publications

Vineet D Menachery

7 joint publications

Xuping Xie